Presentations we supply
- Injection 200 mg
- Injection 1 g
- Injection 1.4 g
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for GemcitabineReference information
Summarised from the product information for Gemcitabine 38 mg/ml concentrate for solution for infusion (UK product information). Always follow the product information approved in your own country.
- Active substance
- Gemcitabine
- Pharmacotherapeutic group
- Antineoplastic agents, pyrimidine analogues (ATC code L01BC05)
- Authorised uses
- Locally advanced or metastatic bladder cancer, with cisplatin
- Locally advanced or metastatic adenocarcinoma of the pancreas
- First-line treatment of locally advanced or metastatic non-small cell lung cancer, with cisplatin
- Relapsed epithelial ovarian cancer, with carboplatin
- Unresectable, locally recurrent or metastatic breast cancer, with paclitaxel
- Storage (unopened)
- Depends on the presentation. The reference concentrate (38 mg/ml) is stored in a refrigerator (2 °C to 8 °C).
- Shelf life (unopened)
- 18 months (unopened vial)
- Container and pack
- Type I clear glass vial with chlorobutyl closure and aluminium flip-off seal; 200 mg/5.3 ml, 1 g/26.3 ml or 2 g/52.6 ml; pack of 1 vial
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Gemcitabine 38 mg/ml concentrate for solution for infusion: www.medicines.org.uk